Ablation Devices Market Insights With Key Players Arthrex, Boston Scientific Corporation, Medtronic ,Intuitive Surgical, Johnson & Johnson, Halyard Health

The global ablation devices market was valued at US$ 3,330.0 million in 2016 and is expected to witness a CAGR of 10.9% during the forecast period (2017 – 2025).

Ablation refers to the removal of certain biological substances from internal parts of the body with the help of ablation devices. Ablation is performed through various techniques such as vaporization, laser, thermal treatments, cryo-treatments, and radiation procedures, among others. In medical sector, ablation is performed usually through surgical methods for the removal of biological substances i.e., usually a small tumor. Other techniques adopted for the removal of infected biological tissues include chemical ablation and radiofrequency ablation.

Ablation gains immense popularity all over the world, as it offers minimally invasive solutions for the removal of tissues or tumors with bearable pain and less recovery period than that of open surgical procedures. Demand for ablation devices is expected to increase owing to increasing incidence of chronic diseases, mainly tumorigenic cancer and other cardiovascular disorders, across the globe. Chronic diseases are major causes of mortality, which resulted in over 38 million deaths worldwide in 2015 according to the World Health Organization (WHO). Moreover, WHO states that cancer is one of the leading causes of death that accounts for up to 8.8 million deaths in 2015. According to Centers of Disease Control and Prevention (CDC), in 2016, an estimated 2.7-6.1 million people in the U.S. suffered from atrial fibrillation. Moreover, the same fact sheet states that around 2% of people younger than the age of 65 years are affected with atrial fibrillation. High prevalence of such diseases will in turn, boost the growth of global ablation devices market.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/464

Factors such as increasing incidence of cardiovascular disorders, rising geriatric population, spreading awareness of the benefits of ablation devices, and rapid technological advances in healthcare sector are propelling growth of the ablation devices market. Cardiovascular disorders such as, atrial fibrillation and arrhythmia, which are highly susceptible to open heart surgeries and can be treated with ablation at earlier stages. North America is the leading region of ablation devices market in terms of sales of ablation devices. The major factors affecting growth of ablation devices market in North America include well-established healthcare infrastructure and substantial expenditure targeted on developing the healthcare facilities. Furthermore, rising demand for minimally invasive surgical procedures, especially in the treatment of cardiac arrhythmia, is also expected to propel the market growth

However, major factors hindering the growth of ablation devices market are costly treatment of ablation surgery and major side effects of surgical ablation procedures such as chemical allergies and strokes.

Key players involved in the strategic implementation of various policies for technological advancements and innovation of ablation devices are,

In 2016, Medtronic expanded its pain therapies portfolio with the launch of OsteoCool RF ablation system. The company expanded its minimally invasive therapy portfolio with the acquisition of the gynecology business from Smith & Nephew.
In 2015, EDAP TMS announced a multinational strategic OEM partnership with Quanta System, which is a leading manufacturer of medical lasers for surgical applications. Through this partnership, Quanta manufactures customized urological stone lasers to be sold under EDAP brand.
In 2015, AtricCure, Inc. acquired nContact, Inc., a privately-held developer of innovative cardiac ablation solutions to provide improved market access to ablation devices.
In 2016, Boston Scientific Corporation acquired Cosman Medical to get its hands on the company’s Radiofrequency Ablation (RFA) system, in order to expand its neuromodulation portfolio.
In 2013, Abbott Laboratories acquired IDEV Technologies, a privately-owned company focused on developing next-generation medical devices for use of ablation catheters in electrophysiology. The company also acquired two other catheter-based medical device companies, namely Advanced Cardiac Therapeutics, Inc. and Topera, Inc. to enter the electrophysiology ablation devices market.

Get Discount On This Report:
https://www.coherentmarketinsights.com/insight/request-discount/464

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.